Apex Research Centre And Hospitals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 15-11-2024
- Paid Up Capital ₹ 0.50 M
as on 15-11-2024
- Company Age 28 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.35 M
as on 15-11-2024
- Satisfied Charges ₹ 8.75 M
as on 15-11-2024
- Revenue -25.23%
(FY 2023)
- Profit -168.91%
(FY 2023)
- Ebitda -124.64%
(FY 2023)
- Net Worth -8.16%
(FY 2023)
- Total Assets -0.82%
(FY 2023)
About Apex Research Centre And Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.35 M. The company has closed loans amounting to ₹8.75 M, as per Ministry of Corporate Affairs (MCA) records.
Rajesh Bhagchandani and Sudhir Lokwani serve as directors at the Company.
- CIN/LLPIN
U85120MP1996PTC011424
- Company No.
011424
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Nov 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Apex Research Centre And Hospitals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajesh Bhagchandani  | Director | 01-Feb-1997 | Current |
| Sudhir Lokwani | Director | 01-Feb-1997 | Current |
Financial Performance of Apex Research Centre And Hospitals.
Apex Research Centre And Hospitals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 25.23% decrease. The company also saw a substantial fall in profitability, with a 168.91% decrease in profit. The company's net worth dipped by a decrease of 8.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Apex Research Centre And Hospitals?
In 2023, Apex Research Centre And Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 18 Nov 2022 | ₹1.35 M | Open |
State Bank Of India Creation Date: 05 Dec 2012 | ₹7.20 M | Satisfied |
I C I C I Bank Ltd Creation Date: 28 Mar 2006 | ₹0.14 M | Satisfied |
How Many Employees Work at Apex Research Centre And Hospitals?
Apex Research Centre And Hospitals has a workforce of 29 employees as of Apr 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Apex Research Centre And Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Apex Research Centre And Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
